More proof-of-concept studies involving the application of functional genes/proteins for key biomarkers for endothelial dysfunction/activation e.g., Vegf; eNOS; pro-coagulation markers such as, SerpineI; Thbd (Thrombomodulin) with an aim to enhance vascular function in early stage vascular diseases is needed. Here, THBD is linked to endothelial dysfunction.